Literature DB >> 24114504

Vitreous hemorrhage secondary to retinal vasculopathy in a patient with dyskeratosis congenita.

Alessandro Finzi1, Mariachiara Morara, Francesco Pichi, Chiara Veronese, Antonio P Ciardella.   

Abstract

The aim of this study was to report a case of vitreous hemorrhage secondary to retinal vasculitis in a patient with dyskeratosis congenita. A 16-year-old white male was referred to the Ophthalmology Clinic due to deterioration of vision in his left eye. Medical history was significant for dyskeratosis congenita associated with thrombocytopenia. General physical examination revealed reticular pigmentation on the upper half of the chest, vertical ridges and splitting of finger nails, and oral mucosal leukoplakia. Ophthalmological examination of the anterior segment was unremarkable. Retinal examination revealed vitreous hemorrhage in the left eye veiling the retinal details. A possible history of trauma was denied. Fundus examination of the right eye showed retinal vascular sheathing with a few dot and blot retinal hemorrhages. Fluorescein angiography revealed extensive areas of non-perfusion beyond the equator in the right eye, later treated with scatter laser photocoagulation. We performed a 23-gauge vitrectomy with endolaser treatment of the new vascularization areas in the left eye. After 6 months, best-corrected visual acuity in the right and left eye was 20/20 and 20/25, respectively. Rather than being confined to anterior segment abnormalities like conjunctivitis, blepharitis and nasolacrimal duct obstruction which are reported in the literature, dyskeratosis congenita can cause significant visual loss due to retinal vasculitis and vitreous hemorrhage. Therefore physicians and ophthalmologists should be aware of this possibility and prompt diagnosis and treatment could prevent further visual loss in such patients.

Entities:  

Mesh:

Year:  2013        PMID: 24114504     DOI: 10.1007/s10792-013-9867-7

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  9 in total

Review 1.  Dyskeratosis congenita in all its forms.

Authors:  I Dokal
Journal:  Br J Haematol       Date:  2000-09       Impact factor: 6.998

2.  Dyskeratosis congenita associated with three malignancies.

Authors:  C Baykal; A Kavak; P Gülcan; N Büyükbabani
Journal:  J Eur Acad Dermatol Venereol       Date:  2003-03       Impact factor: 6.166

3.  Bilateral retinal vasculopathy in a patient with dyskeratosis congenita.

Authors:  Luiz F Teixeira; Carol L Shields; Brian Marr; Noel Horgan; Jerry A Shields
Journal:  Arch Ophthalmol       Date:  2008-01

4.  Dyskeratosis congenita.

Authors:  H R Davidson; J M Connor
Journal:  J Med Genet       Date:  1988-12       Impact factor: 6.318

5.  Ocular and orbital manifestations of the inherited bone marrow failure syndromes: Fanconi anemia and dyskeratosis congenita.

Authors:  Ekaterini T Tsilou; Neelam Giri; Sarah Weinstein; Christine Mueller; Sharon A Savage; Blanche P Alter
Journal:  Ophthalmology       Date:  2009-12-22       Impact factor: 12.079

6.  Retinal hemorrhages in a patient with dyskeratosis congenita.

Authors:  Sayeda Nazir; Namrata Sayani; Paul H Phillips
Journal:  J AAPOS       Date:  2008-05-02       Impact factor: 1.220

Review 7.  Dyskeratosis congenita: clinical features and genetic aspects. Report of a family and review of the literature.

Authors:  C Sirinavin; A A Trowbridge
Journal:  J Med Genet       Date:  1975-12       Impact factor: 6.318

8.  Thrombocytopenia: first symptom in a patient with dyskeratosis congenita.

Authors:  K De Boeck; H Degreef; R Verwilghen; L Corbeel; M Casteels-Van Daele
Journal:  Pediatrics       Date:  1981-06       Impact factor: 7.124

9.  The telomerase database.

Authors:  Joshua D Podlevsky; Christopher J Bley; Rebecca V Omana; Xiaodong Qi; Julian J-L Chen
Journal:  Nucleic Acids Res       Date:  2007-12-11       Impact factor: 16.971

  9 in total
  4 in total

1.  Bilateral Proliferative Retinopathy Associated With Hoyeraal-Hreidarsson Syndrome, a Severe Form of Dyskeratosis Congenita.

Authors:  Michael J Allingham
Journal:  Ophthalmic Surg Lasers Imaging Retina       Date:  2016-04-01       Impact factor: 1.300

2.  Frosted Branch Angiitis in Pediatric Dyskeratosis Congenita: A Case Report.

Authors:  Xiao-Yu Zheng; Jia Xu; Wei Li; Si-Si Li; Cai-Ping Shi; Zheng-Yan Zhao; Jian-Hua Mao; Xi Chen
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

Review 3.  Fanconi anemia and dyskeratosis congenita/telomere biology disorders: Two inherited bone marrow failure syndromes with genomic instability.

Authors:  Moisés Ó Fiesco-Roa; Benilde García-de Teresa; Paula Leal-Anaya; Renée van 't Hek; Talia Wegman-Ostrosky; Sara Frías; Alfredo Rodríguez
Journal:  Front Oncol       Date:  2022-08-25       Impact factor: 5.738

Review 4.  The diagnosis and treatment of dyskeratosis congenita: a review.

Authors:  M Soledad Fernández García; Julie Teruya-Feldstein
Journal:  J Blood Med       Date:  2014-08-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.